TREA

79302096 - PREVENTIS

Follow

Information

  • Trademark
  • 79302096
  • Serial Number
    79302096
  • Registration Number
    6681425
  • Filing Date
    December 04, 2020
    4 years ago
  • Registration Date
    March 29, 2022
    2 years ago
  • Transaction Date
    November 30, 2023
    a year ago
  • Status Date
    March 29, 2022
    2 years ago
  • Published for Opposition Date
    January 11, 2022
    2 years ago
  • Location Date
    March 29, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BULLOFF, TOBY ELLEN
  • Attorney Docket Number
    6769-0119US1
    Attorney Name
    Michael T. Smith
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
PREVENTIS
Case File Statements
  • GS0051: diagnostic and analytical means for medical purposes in particular chemical preparations for use in disease prevention, namely, for detecting and preventing infectious diseases, in particular, infectious diseases caused by viruses, namely, influenza virus, SARS, RSV, infectious diseases caused by bacteria, namely, leptospirosis, Lyme disease, gonorrhea, syphilis, Helicobacter pylori infection, botulism, tetanus, meningitis, pneumonia, endocarditis, Pink eye, erysipelas, necrotizing fasciitis, chlamydia infection, tuberculosis, infectious diseases caused by monocellular organisms, namely, fungi, amoebozoa, entamoebia, dermatophytesm, ringworm, tinea, tinea pedis, oncological diseases, namely, colorectal cancer, cancers of colon, bladder, testicles, prostate, lymphoma, gastroenterological diseases, namely, morbus Crohn, celiac disease, inflammatory bowel syndrome (IBS), inflammatory bowel disease (IBD), diseases and conditions diagnosed by gluten-derived immunogenic peptides (GIP) in stool, urine, diseases of the bones, gastrointestinal diseases increasing the concentration of calprotectin in blood, serum, feces, gastrointestinal syndromes, metabolic diseases, diseases caused by unbalanced vitamin supply and malnutrition, in particular, vitamin D, vitamin B1, vitamin B12, diseases affecting the concentration of the Thyroid-stimulating hormone (TSH), C-reactive protein (CRP), D-Dimer, microalbumin in bodily fluids, urine, and stool, cardiovascular diseases, namely, myocardial infarct, diseases affecting the troponin-level in bodily fluids, conditions affecting women's health, in particular, the concentration of choriogonadotropin, ollicle-stimulating hormone (FSH), luteinizing hormone (LH) in bodily fluids and urine; chemical preparations for use in medical and pharmaceutical detection kits, namely, for detecting infectious diseases, in particular, infectious diseases caused by viruses, namely, influenza virus, SARS, RSV, infectious diseases caused by bacteria, namely, leptospirosis, Lyme disease, gonorrhea, syphilis, Helicobacter pylori infection, botulism, tetanus, meningitis, pneumonia, endocarditis, Pink eye, erysipelas, necrotizing fasciitis, chlamydia infection, tuberculosis, infectious diseases caused by monocellular organisms, namely, fungi, amoebozoa, entamoebia, dermatophytesm, ringworm, tinea, tinea pedis, oncological diseases, namely, colorectal cancer, cancers of colon, bladder, testicles, prostate, lymphoma, gastroenterological diseases, namely, morbus Crohn, celiac disease, inflammatory bowel syndrome (IBS), inflammatory bowel disease (IBD), diseases and conditions diagnosed by gluten-derived immunogenic peptides (GIP) in stool, urine, diseases of the bones, gastrointestinal diseases increasing the concentration of calprotectin in blood, serum, feces, gastrointestinal syndromes, metabolic diseases, diseases caused by unbalanced vitamin supply and malnutrition, in particular, vitamin D, vitamin B1, vitamin B12, diseases affecting the concentration of the Thyroid-stimulating hormone (TSH), C-reactive protein (CRP), D-Dimer, microalbumin in bodily fluids, urine, and stool, cardiovascular diseases, namely, myocardial infarct, diseases affecting the troponin-level in bodily fluids, conditions affecting women's health, in particular, the concentration of choriogonadotropin, ollicle-stimulating hormone (FSH), luteinizing hormone (LH) in bodily fluids and urine; chemicals for medical diagnostics and analysis relating to infectious diseases, in particular, infectious diseases caused by viruses, namely, influenza virus, SARS, RSV, infectious diseases caused by bacteria, namely, leptospirosis, Lyme disease, gonorrhea, syphilis, Helicobacter pylori infection, botulism, tetanus, meningitis, pneumonia, endocarditis, Pink eye, erysipelas, necrotizing fasciitis, chlamydia infection, tuberculosis, infectious diseases caused by monocellular organisms, namely, fungi, amoebozoa, entamoebia, dermatophytesm, ringworm, tinea, tinea pedis, oncological diseases, namely, colorectal cancer, cancers of colon, bladder, testicles, prostate, lymphoma, gastroenterological diseases, namely, morbus Crohn, celiac disease, inflammatory bowel syndrome (IBS), inflammatory bowel disease (IBD), diseases and conditions diagnosed by gluten-derived immunogenic peptides (GIP) in stool, urine, diseases of the bones, gastrointestinal diseases increasing the concentration of calprotectin in blood, serum, feces; gastrointestinal syndromes, metabolic diseases, diseases caused by unbalanced vitamin supply and malnutrition, in particular, vitamin D, vitamin B1, vitamin B12, diseases affecting the concentration of the Thyroid-stimulating hormone (TSH), C-reactive protein (CRP), D-Dimer, microalbumin in bodily fluids, urine, and stool, cardiovascular diseases, namely, myocardial infarct, diseases affecting the troponin-level in bodily fluids, conditions affecting women's health, in particular, the concentration of choriogonadotropin, ollicle-stimulating hormone (FSH), luteinizing hormone (LH) in bodily fluids and urine; all the aforesaid goods not for veterinary use; chemicals for medical diagnostics and analysis in the nature of chemical preparations for rapid testing of infectious diseases caused by viruses, namely, influenza virus, SARS, RSV, infectious diseases caused by bacteria, namely, leptospirosis, Lyme disease, gonorrhea, syphilis, Helicobacter pylori infection, botulism, tetanus, meningitis, pneumonia, endocarditis, Pink eye, erysipelas, necrotizing fasciitis, chlamydia infection, tuberculosis, infectious diseases caused by monocellular organisms, namely, fungi, amoebozoa, entamoebia, dermatophytesm, ringworm, tinea, tinea pedis, oncological diseases, namely, colorectal cancer, cancers of colon, bladder, testicles, prostate, lymphoma, gastroenterological diseases, namely, morbus Crohn, celiac disease, inflammatory bowel syndrome (IBS), inflammatory bowel disease (IBD), diseases and conditions diagnosed by gluten-derived immunogenic peptides (GIP) in stool, urine, diseases of the bones, gastrointestinal diseases increasing the concentration of calprotectin in blood, serum, feces, gastrointestinal syndromes, metabolic diseases, diseases caused by unbalanced vitamin supply and malnutrition, in particular, vitamin D, vitamin B1, vitamin B12, diseases affecting the concentration of the Thyroid-stimulating hormone (TSH), C-reactive protein (CRP), D-Dimer, microalbumin in bodily fluids, urine, and stool, cardiovascular diseases, namely, myocardial infarct, diseases affecting the troponin-level in bodily fluids, conditions affecting women's health, in particular, the concentration of choriogonadotropin, ollicle-stimulating hormone (FSH), luteinizing hormone (LH) in bodily fluids and urine
Case File Event Statements
  • 11/30/2023 - a year ago
    30 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 9/11/2022 - 2 years ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/19/2022 - 2 years ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/19/2022 - 2 years ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/29/2022 - 2 years ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/29/2022 - 2 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/11/2022 - 2 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/11/2022 - 2 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/10/2022 - 2 years ago
    22 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/22/2021 - 3 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/22/2021 - 3 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/22/2021 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/9/2021 - 3 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/9/2021 - 3 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/9/2021 - 3 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/9/2021 - 3 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/9/2021 - 3 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/22/2021 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/22/2021 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/22/2021 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/13/2021 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/21/2021 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/21/2021 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/20/2021 - 3 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/19/2021 - 3 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/14/2021 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/26/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/21/2021 - 3 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/19/2021 - 3 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 1/7/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC